Endothelial dysfunction in young healthy men is associated with aspirin resistance

Vane, 1990, Regulatory functions of the vascular endothelium, NEJM, 323, 27, 10.1056/NEJM199007053230106 Davignon, 2004, Role of endothelial dysfunction in atherosclerosis, Circulation, 109, III-27, 10.1161/01.CIR.0000131515.03336.f8 Cardillo, 1998, Selective defect in nitric oxide synthesis may explain the impaired endothelium dependent vasodilation in patients with essential hypertension, Circulation, 97, 851, 10.1161/01.CIR.97.9.851 Chan, 2003, The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease, J Am Coll Cardiol, 42, 1037, 10.1016/S0735-1097(03)00927-6 2002, Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 U.S. Preventive Services Task Force, 2002, Aspirin for the primary prevention of cardiovascular events: recommendation and rationale, Ann Intern Med, 136, 157, 10.7326/0003-4819-136-2-200201150-00015 Kranzhofer, 2006, Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism, Platelets, 17, 163, 10.1080/09537100500441101 Cipollone, 2000, Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina, Circulation, 102, 1007, 10.1161/01.CIR.102.9.1007 Sanderson, 2005, Narrative review: AR and its clinical implications, Ann Intern Med, 142, 370, 10.7326/0003-4819-142-5-200503010-00012 Heitzer, 2001, Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease, Circulation, 104, 2673, 10.1161/hc4601.099485 Doroszko, 2011, Role of the nitric oxide metabolic pathway and prostanoids in the pathogenesis of endothelial dysfunction and essential hypertension in young men, Hypertens Res, 34, 79, 10.1038/hr.2010.169 Foster, 1993, Aspirin as a therapeutic agent in cardiovascular disease, Circulation, 87, 659, 10.1161/01.CIR.87.2.659 Bots, 2005, Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response, Eur Heart J, 26, 363, 10.1093/eurheartj/ehi017 Paniccia, 2009, Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy, Am J Clin Pathol, 131, 834, 10.1309/AJCPTE3K1SGAPOIZ Fitzgerald, 2011, Aspirin resistance: effect of clinical, biochemical and genetic factors, Pharmacol Ther, 130, 213, 10.1016/j.pharmthera.2011.01.011 Gum, 2001, Profile and prevalence of aspirin resistance in patients with cardiovascular disease, Am J Cardiol, 88, 230, 10.1016/S0002-9149(01)01631-9 Tóth, 2006, Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood, Thromb Haemost, 96, 781, 10.1160/TH06-05-0242 Celermajer, 1992, Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis, Lancet, 340, 1111, 10.1016/0140-6736(92)93147-F Böger, 1998, Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia, Circulation, 98, 1842, 10.1161/01.CIR.98.18.1842 Esterbauer, 1991, Chemistry and biochemistry of hydroxynonenal, malonyldialdehyde and related aldehydes, Free Rad Biol Med, 11, 81, 10.1016/0891-5849(91)90192-6 Wendell, 1970, Measurement of oxidized glutathione and total glutathione in the perfused rat heart, Biochem J, 117, 661, 10.1042/bj1170661 Guntherberg, 1966, The true oxidized glutathione content of red blood cells obtained by new enzymatic and paper chromatographic methods, Anal Biochem, 15, 205, 10.1016/0003-2697(66)90025-X Kooy, 1997, Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite, Crit Care Med, 25, 812, 10.1097/00003246-199705000-00017 Kaur, 1994, Evidence for nitric-oxide-mediated oxidative damage in chronic inflammation: nitrotyrosine in serum and synovial fluid from rheumatoid patients, FEBS Lett, 350, 9, 10.1016/0014-5793(94)00722-5 Loscalzo, 2001, Nitric oxide insufficiency, platelet activation, and arterial thrombosis, Circ Res, 88, 756, 10.1161/hh0801.089861 Vanhoutte, 1991, Endothelium-dependent contractions, Blood Vessels, 28, 74 O'Kane, 2009, Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity, Cardiovasc Res, 83, 123, 10.1093/cvr/cvp120 Kumar, 2012, Calreticulin transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds, Nitric Oxide, 26, 9, 10.1016/j.niox.2011.10.003 Racz, 2010, Cyclooxygenase-2 derived thromboxane A(2) and reactive oxygen species mediate flow-induced constrictions of venules in hyperhomocysteinemia, Atherosclerosis, 208, 43, 10.1016/j.atherosclerosis.2009.06.014 Poulsen, 2005, A critical appraisal of the phenomenon of AR, Cardiology, 104, 83, 10.1159/000086690 Shen, 2009, Aspirin resistance in healthy drug-naïve men versus women (from the Heredity and Phenotype Intervention [HAPI] Heart Study), Am J Cardiol, 104, 606, 10.1016/j.amjcard.2009.04.027 Cheng, 2007, Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease, J Clin Pharm Ther, 32, 287, 10.1111/j.1365-2710.2007.00823.x Gupta, 2011, Endothelial dysfunction and inflammation in different stages of essential hypertension, Saudi J Kidney Dis Transpl, 22, 97 Steinhubl, 2009, Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding, Ann Intern Med, 150, 379, 10.7326/0003-4819-150-6-200903170-00006 Moens, 2005, Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool?, Chest, 127, 2254, 10.1378/chest.127.6.2254 Adams, 1998, Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis, J Am Coll Cardiol, 32, 123, 10.1016/S0735-1097(98)00206-X